SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.

about

Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.

P2860

Q48522177-9BF6E82B-E132-4E64-84BC-057C84F4E93F

P2860

SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.

Item

http://www.wikidata.org/entity/Q51414305

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@en

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@nl

type

Item

label

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@en

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@nl

prefLabel

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@en

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@nl

P1476

SET protein overexpression con ...... ells through PI3K/Akt pathway.

@en

P2093

Haisheng You

http://www.w3.org/2001/XMLSchema#string

Jianfeng Xing

http://www.w3.org/2001/XMLSchema#string

Siying Chen

http://www.w3.org/2001/XMLSchema#string

Ti Meng

http://www.w3.org/2001/XMLSchema#string

Weipeng Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaowei Zheng

http://www.w3.org/2001/XMLSchema#string

Yalin Dong

http://www.w3.org/2001/XMLSchema#string

P2860

The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing

Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.

Phosphorylation of SET protein at Ser171 by protein kinase D2 diminishes its inhibitory effect on protein phosphatase 2A

Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy

Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.

Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT-mTOR pathway.

Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor.

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome.

A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells

P304

255-263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1061186X.2016.1245307

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27718638

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.

about

P2860

P2860

SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921